Atorvastatin Modulates Th1/Th2 Response in Patients With Chronic Heart Failure

Journal of Cardiac Failure

Volumn 15, Issue 2, 2009, Pages 158-162

  Cheng, Xiang ^a   Ding, Yingjun ^a   Xia, Chunyan ^a   Tang, Tingting ^a   Yu, Xian ^a   Xie, Jiangjiao ^a   Liao, Mengyang ^a   Yao, Rui ^a   Chen, Yong ^a   Wang, Min ^a   Liao, Yu Hua ^a  

^a Union Hospital   (China)

Author keywords

Chronic heart failure; helper; HMG CoA reductase inhibitor; T lymphocyte

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; HEART FAILURE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TH1 CELL; TH2 CELL;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HEART FAILURE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; IMMUNOENZYME TECHNIQUES; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-18; INTERLEUKIN-4; MALE; MIDDLE AGED; PYRROLES; TH1 CELLS; TH2 CELLS;

EID: 61349194501     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2008.10.001     Document Type: Article

References (26)

1. Torre-Amione G. Immune activation in chronic heart failure. Am J Cardiol 95 (2005) 3C-8C
2. Cheng X., Liao Y.H., Ge H.X., Li B., Zhang J.Y., Yuan J., et al. Th1/Th2 functional imbalance after acute myocardial infarction: coronary arterial inflammation or myocardial inflammation. J Clin Immunol 25 (2005) 246-253
3. Yu Q., Watson R.R., Marchalonis J.J., and Larson D.F. A role for T lymphocytes in mediating cardiac diastolic function. Am J Physiol Heart Circ Physiol 289 (2005) H643-H651
4. Rogge L. A genomic view of helper T cell subsets. Ann N Y Acad Sci 975 (2002) 57-67
5. D'Elios M., and Del Prete G. Th1/Th2 balance in human disease. Transplant Proc 30 (1998) 2373-2377
6. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 97 (1998) 1440-1445
7. Hasegawa H., Yamamoto R., Takano H., Mizukami M., Asakawa M., Nagai T., et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors prevent the development of cardiac hypertrophy and heart failure in rats. J Mol Cell Cardiol 35 (2003) 953-960
8. Stanislaus R., Gilg A.G., Singh A.K., and Singh I. Immunomodulation of experimental autoimmune encephalomyelitis in the Lewis rats by lovastatin. Neurosci Lett 333 (2002) 167-170
9. Cheng X., Liao Y.H., Zhang J.Y., Li B., Ge H.X., Yuan J., et al. Effects of atorvastatin on Th polarization in patients with acute myocardial infarction. Eur J Heart Fail 7 (2005) 1099-1104
10. Youssef S., Stüve O., Patarroyo J.C., Ruiz P.J., Radosevich J.L., Hur E.M., et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420 (2002) 78-84
11. Aktas O., Waiczies S., Smorodchenko A., Dorr J., Seeger B., Prozorvski T., et al. Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin. J Exp Med 197 (2003) 725-733
12. Kwak B., Mulhaupt F., Myit S., and Mach F. Statins as a newly recognized type of immunomodulator. Nat Med 6 (2000) 1399-1402
13. Yamaoka-Tojo M., Tojo T., Inomata T., Machida Y., Osada K., and Izumi T. Circulating levels of interleukin 18 reflect etiologies of heart failure: Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure. J Card Fail 8 (2002) 21-27
14. Kelso A., Troutt A.B., Maraskovsky E., Gough N.M., Morris L., Pech M.H., et al. Heterogeneity in lymphokine profiles of CD4+ and CD8+ T cells and clones activated in vivo and in vitro. Immunol Rev 123 (1991) 85-114
15. Koglin J., Glysing-Jensen T., Mudgett J.S., and Russell M.E. Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice. Circulation 97 (1998) 2059-2065
16. Yndestad A., Holm A.M., Müller F., Simonsen S., Frøland S.S., Gullestad L., et al. Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc Res 60 (2003) 141-146
17. Kalinowski L., Dobrucki L.W., Brovkovych V., and Malinski T. Increased nitric oxide bioavailability in endothelial cells contributes to the pleiotropic effect of cerivastatin. Circulation 105 (2002) 933-938
18. Shovman O., Levy Y., Gilburd B., and Shoenfeld Y. Antiinflammatory and immunomodulatory properties of statins. Immunol Res 25 (2002) 271-285
19. Sola S., Mir M.Q., Lerakis S., Tandon N., and Khan B.V. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure. J Am Coll Cardiol 47 (2006) 332-337
20. Tousoulis D., Charakida M., Stefanadi E., Siasos G., Latsios G., and Stefanadis C. Statins in heart failure. Beyond the lipid lowering effect. Int J Cardiol 115 (2007) 144-150
21. Li W.M., Liu W., Gao C., and Zhou B.G. Immunoregulatory effects of atorvastatin on experimental autoimmune myocarditis in Lewis rats. Immunol Cell Biol 84 (2006) 274-280
22. Hakamada-Taguchi R., Uehara Y., Kuribayashi K., Numabe A., Saito K., Negoro H., et al. Inhibition of hydroxymethylglutaryl-coenzyme a reductase reduces Th1 development and promotes Th2 development. Circ Res 93 (2003) 948-956
23. Coward W., and Chow S.C. Effect of atorvastatin on TH1 and TH2 cytokine secreting cells during T cell activation and differentiation. Atherosclerosis 186 (2006) 302-309
24. Palinski W., and Tsimikas S. Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis. J Am Soc Nephrol 13 (2002) 1673-1681
25. Mestas J., and Hughes C.C. Of mice and not men: differences between mouse and human immunology. J Immunol 172 (2004) 2731-2738
26. Shimada K., Miyauchi K., and Daida H. Early intervention with atorvastatin modulates TH1/TH2 imbalance in patients with acute coronary syndrome: from bedside to bench. Circulation 109 (2004) e213-e214